Y-mAbs Therapeutics, Inc.

Y-mAbs Therapeutics, Inc.

YMAB
Y-mAbs Therapeutics, Inc.US flagNASDAQ Global Select
8.61
USD
+0.02
- -
391.22MMarket Cap

Income Statement (USD)

APIChatGPT
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Sales/Revenue/Turnover
- -
- -
- -
- -
21
35
65
85
88
+ Sales & Services Revenue
- -
- -
- -
- -
21
35
65
85
88
- Cost of Revenue
- -
- -
- -
- -
2
3
8
11
15
+ Cost of Goods & Services
- -
- -
- -
- -
2
3
8
11
15
Gross Profit
- -
- -
- -
- -
19
32
58
73
72
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Operating Expenses
17
19
43
83
138
148
153
99
104
+ Selling, General & Admin
3
5
9
20
45
55
61
45
55
+ Research & Development
14
14
34
63
94
93
92
54
49
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Income (Loss)
-17
-19
-43
-83
-120
-115
-95
-26
-31
- Non-Operating (Income) Loss
- -
- -
- -
-2
-1
-60
1
-5
-1
+ Interest Expense, Net
- -
- -
- -
-2
-1
2
1
-5
-1
+ Interest Expense
- -
- -
- -
- -
- -
2
1
- -
- -
- Interest Income
- -
- -
- -
2
1
- -
- -
5
1
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
-62
- -
- -
- -
Pretax Income
-17
-19
-43
-81
-119
-55
-96
-21
-30
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
1
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-17
-19
-43
-81
-119
-55
-96
-21
-30
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-17
-19
-43
-81
-119
-55
-96
-21
-30
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-17
-19
-43
-81
-119
-55
-96
-21
-30
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-17
-19
-43
-81
-119
-55
-96
-21
-30
EBIT
-17
-19
-43
-83
-120
-115
-95
-26
-31
EBITDA
-17
-19
-43
-83
-120
-115
-94
-25
-31
EBITDA Margin (%)
- -
- -
- -
- -
-576.09
-328.54
-143.98
-29.4
-34.97
EBITA
-17
-19
-43
-83
-120
-115
-95
-26
-31
Gross Margin (%)
- -
- -
- -
- -
89.38
92.8
88.41
86.54
82.61
Operating Margin (%)
- -
- -
- -
- -
-578
-330.78
-145.27
-30.27
-35.58
Profit Margin (%)
- -
- -
- -
- -
-575.12
-158.39
-146.43
-25.26
-33.83
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
1
1
1
1
Basic Weighted Avg Shares
33
33
29
35
40
43
44
44
44
Basic EPS, GAAP
-0.51
-0.58
-1.5
-2.3
-2.97
-1.28
-2.19
-0.49
-0.67
Basic EPS from Cont Ops
-0.51
-0.58
-1.5
-2.3
-2.97
-1.28
-2.19
-0.49
-0.67
Diluted Weighted Avg Shares
33
33
29
35
40
43
44
44
44
Diluted EPS, GAAP
-0.51
-0.58
-1.5
-2.3
-2.97
-1.28
-2.19
-0.49
-0.67
Diluted EPS from Cont Ops
-0.51
-0.58
-1.5
-2.3
-2.97
-1.28
-2.19
-0.49
-0.67

Balance Sheet (USD)

APIChatGPT
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
Total Current Assets
17
91
152
212
122
202
130
111
99
+ Cash, Cash Equivalents & STI
17
90
148
207
115
182
106
79
67
+ Cash & Cash Equivalents
17
90
148
207
115
182
106
79
67
+ ST Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
8
13
22
20
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
8
13
22
20
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
6
7
5
7
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
5
6
2
- -
+ Finished Goods
- -
- -
- -
- -
- -
1
1
3
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
7
+ Other ST Assets
- -
1
4
5
8
7
5
5
4
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
1
- -
4
10
11
11
17
21
+ Property, Plant & Equip, Net
- -
- -
- -
4
6
6
2
2
1
+ Property, Plant & Equip
- -
- -
- -
4
6
6
2
2
1
- Accumulated Depreciation
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
1
- -
- -
3
5
9
15
21
+ Total Intangible Assets
- -
- -
- -
- -
- -
2
3
3
2
+ Goodwill
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
2
3
3
2
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
1
- -
- -
3
3
6
12
18
Total Assets
17
92
152
216
132
213
141
128
120
+ Payables & Accruals
3
7
8
12
15
24
25
15
19
+ Accounts Payable
2
6
6
9
9
14
14
6
7
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
1
2
3
6
11
11
9
12
+ ST Debt
- -
- -
- -
1
2
2
1
1
1
+ ST Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
1
2
2
1
1
1
+ Other ST Liabilities
- -
1
1
1
3
2
2
4
4
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
1
1
1
3
2
2
4
4
Total Current Liabilities
3
8
9
14
20
28
28
20
24
+ LT Debt
- -
- -
- -
2
2
2
1
1
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
2
2
2
1
1
- -
+ Other LT Liabilities
2
2
2
2
5
3
3
6
4
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
2
2
2
2
5
3
3
6
4
Total Noncurrent Liabilities
2
2
2
4
7
5
4
7
4
Total Liabilities
5
10
11
17
26
33
32
27
28
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
34
124
225
365
392
519
544
558
577
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
34
124
225
365
392
519
544
558
577
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-22
-42
-85
-166
-285
-340
-436
-457
-487
+ Other Equity
- -
- -
- -
- -
-1
1
1
- -
2
Equity Before Minority Interest
12
82
141
199
106
180
109
101
92
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
12
82
141
199
106
180
109
101
92
Total Liabilities & Equity
17
92
152
216
132
213
141
128
120
Shares Outstanding
33
34
34
40
41
44
44
44
45
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
2
4
4
2
1
1
Net Debt
-17
-90
-148
-207
-115
-182
-106
-79
-67
Net Debt to Equity
-139.91
-110.14
-105.2
-104.14
-108.31
-100.81
-96.83
-77.87
-73.08
Tangible Common Equity Ratio
69.87
89.17
92.5
91.93
80.15
84.52
76.72
78.53
76.28
Current Ratio
5.8
11.53
16.61
15.6
6.26
7.26
4.61
5.52
4.16
Cash Conversion Cycle
- -
- -
- -
- -
-1,482.2
-80.79
-226.66
-114.25
101.21

Cash Flow Statement (USD)

APIChatGPT
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
As of date
12/31/2016
12/31/2017
12/31/2018
12/31/2019
12/31/2020
12/31/2021
12/31/2022
12/31/2023
12/31/2024
+ Net Income
-17
-19
-43
-81
-119
-55
-96
-21
-30
+ Depreciation & Amortization
- -
- -
- -
- -
- -
1
1
1
1
+ Non-Cash Items
3
1
2
5
24
-41
29
13
17
+ Stock-Based Compensation
- -
1
2
5
16
19
26
14
15
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
2
- -
- -
- -
8
-60
4
-1
3
+ Chg in Non-Cash Work Cap
3
3
- -
3
3
-7
-10
-20
-4
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
-8
-5
-10
2
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
-6
-1
-5
-8
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc (Dec) in Accts Payable
4
3
3
4
8
6
-1
-5
1
+ Inc (Dec) in Other
- -
- -
-3
-1
-4
- -
-3
- -
1
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-11
-16
-41
-73
-91
-103
-76
-27
-16
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
-2
- -
-1
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
-2
- -
-1
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
19
90
100
135
- -
108
- -
- -
- -
+ Increase in Capital Stock
19
90
100
135
- -
108
- -
- -
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
-3
62
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
-2
-3
61
- -
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Financing Activities
- -
- -
-1
- -
2
1
- -
- -
4
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
19
90
99
135
2
108
- -
- -
4
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
8
74
57
59
-92
67
-76
-27
-11
EBITDA
-17
-19
-43
-83
-120
-115
-94
-25
-31
EBITDA Margin (%)
- -
- -
- -
- -
-576.09
-328.54
-143.98
-29.4
-34.97
Free Cash Flow
-11
-16
-41
-75
-91
-104
-76
-27
-16
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-16
-41
-75
-91
-103
-76
-27
-16
Free Cash Flow per Basic Share
-0.34
-0.48
-1.44
-2.14
-2.28
-2.4
-1.74
-0.62
-0.35
Price/Free Cash Flow
- -
- -
-14.28
-15.37
-21.81
-6.89
-2.81
-10.93
-22.09
Cash Flow to Net Income
0.65
0.83
0.95
0.91
0.76
1.86
0.79
1.27
0.53
Capital Expenditures
- -
- -
- -
-2
- -
-1
- -
- -
- -